Bespoke Extracts (BSPK) Non Operating Income (2016 - 2025)
Bespoke Extracts' (BSPK) quarterly Non Operating Income came in at -$24197.0 in Q3 2025, down 84.08% year-on-year from -$151968.3 in Q3 2024, and up 43.92% quarter-over-quarter from -$43148.0 in Q2 2025.
Bespoke Extracts (BSPK) Non Operating Income (2016 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Non Operating Income across 10 years of filings, most recently posting -$24197.0 for Q3 2025.
- Non Operating Income for Q3 2025 came in at -$24197.0, down 84.08% year-over-year; the trailing twelve-month figure through Sep 2025 was -$90263.0 (down 129.76% YoY), and the FY2024 annual result was -$42847.0, down 294.36% from the prior year.
- Non Operating Income came in at -$24197.0 for Q3 2025 at Bespoke Extracts, up from -$43148.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $294917.0 in Q4 2021 to a low of -$96450.0 in Q4 2022.
- The 5-year median for Non Operating Income is -$6536.0 (2023), against an average of $4362.3.
- Peak annual rise in Non Operating Income reached 1419.34% in 2023, while the deepest fall reached 1293.96% in 2023.
- Bespoke Extracts' Non Operating Income stood at $294917.0 in 2021, then sank by 132.7% to -$96450.0 in 2022, then jumped by 95.67% to -$4173.0 in 2023, then sank by 85.36% to -$7735.0 in 2024, then slumped by 212.82% to -$24197.0 in 2025.
- The last three Non Operating Income figures came in at -$24197.0 (Q3 2025), -$43148.0 (Q2 2025), and -$15183.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | -24,197.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -24,197.00 |
| Jun 30, 2025 | -43,148.00 |
| Mar 31, 2025 | -15,183.00 |
| Dec 31, 2024 | -7,735.00 |
| Sep 30, 2024 | -13,145.00 |
| Jun 30, 2024 | -10,652.00 |
| Mar 31, 2024 | -11,315.00 |
| Dec 31, 2023 | -4,173.00 |
| Sep 30, 2023 | -5,337.00 |
| Jun 30, 2023 | 2,587.00 |
| Mar 31, 2023 | 2,750.00 |
| Dec 31, 2022 | -96,450.00 |
| Sep 30, 2022 | 447.00 |
| Jun 30, 2022 | 250.00 |
| Mar 31, 2022 | 181.00 |
| Nov 30, 2021 | 294,917.00 |
| May 31, 2020 | -242,188.00 |
| Feb 29, 2020 | -365,251.00 |
| Nov 30, 2019 | -17,844.00 |
| Aug 31, 2019 | -1.00 |